Cargando…
Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report
Patient: Male, 41-year-old Final Diagnosis: Bilateral otitis media with cholesteatoma Symptoms: Hearing loss Medication: — Clinical Procedure: — Specialty: Otolaryngology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Obliteration of the mastoid cavity with S53P4 bioactive glass is...
Autores principales: | Król, Bartłomiej, Porowski, Marek, Cywka, Katarzyna B., Skarżyńska, Magdalena B., Skarżyński, Piotr Henryk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666435/ https://www.ncbi.nlm.nih.gov/pubmed/33168798 http://dx.doi.org/10.12659/AJCR.925914 |
Ejemplares similares
-
Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results
por: Król, Bartłomiej, et al.
Publicado: (2021) -
The Bonebridge BCI 602 Active Transcutaneous Bone Conduction Implant in Children: Objective and Subjective Benefits
por: Cywka, Katarzyna B., et al.
Publicado: (2021) -
Evaluation of the Bonebridge BCI 602 active bone conductive implant in adults: efficacy and stability of audiological, surgical, and functional outcomes
por: Cywka, Katarzyna B., et al.
Publicado: (2022) -
Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
por: Remangeon, Françoise, et al.
Publicado: (2020) -
Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study
por: Alciato, Lauranne, et al.
Publicado: (2022)